By MELINDA J. OVERSTREET for Glasgow News 1 In September 2023, he had been fighting a cold for weeks and weeks. His immune ...

I share how traveling fueled my passion for life, how myeloma changed my journeys, and how new mobility options have opened ...

Celltrion USA today announced that STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo), biosimilars referencing PROLIA® ...

Multiple myeloma begins when abnormal cells multiply and grow uncontrollably in a person’s bone marrow, crowding out healthy ...

New criteria make high-risk smoldering multiple myeloma treatable, opening door to future 'chronic' disease status ...

Fresenius Kabi’s fifth and sixth biosimilars Conexxence (denosumab-bnht) and Bomyntra (denosumab-bnht) have launched in the ...

Fatigue, bone pain, and frequent infections can all be signs of the blood cancer multiple myeloma, which often has no early distinctive symptoms.

Multiple myeloma bone lesions occur when cancerous cells cause the bones to form weak spots, which can lead to breaks. Learn more about lesions and pain.

Kyphoplasty is being used to treat painful osteolytic or fractured vertebrae, but will it become a key treatment option for patients with vertebral osteolyses from multiple myeloma?

Like many closely-knit mothers and daughters, Noreen and Anne Hennessy love nothing more than hitting the shops together at ...

Fresenius announced that its operating company, Fresenius Kabi, has introduced two new biosimilars – Conexxence ...

EXCLUSIVE: A top doctor has shared five common symptoms which could be a sign that something is seriously wrong.